ATP5J
Gene Information
- Official Symbol: ATP5PF
- Official Name: ATP synthase peripheral stalk subunit F6
- Aliases and Previous Symbols: N/A
- Entrez ID: 522
- UniProt: P18859
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. Also involved in the restoration of oligomycin-sensitive ATPase activity to depleted F1-F0 complexes.
Pfam Domains GO Terms
Pfam Domains
| ATP-synt F6 |
GO Terms
| negative regulation of prostaglandin secretion |
| negative regulation of arachidonic acid secretion |
| negative regulation of icosanoid secretion |
| negative regulation of fatty acid transport |
| regulation of arachidonic acid secretion |
| mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) |
| regulation of prostaglandin secretion |
| proton transmembrane transporter activity |
| mitochondrial proton-transporting ATP synthase complex |
| regulation of icosanoid secretion |
| negative regulation of organic acid transport |
| mitochondrial ATP synthesis coupled proton transport |
| response to muscle activity |
| positive regulation of heart rate |
| energy coupled proton transport, down electrochemical gradient |
| ATP synthesis coupled proton transport |
| negative regulation of lipid transport |
| regulation of fatty acid transport |
| negative regulation of anion transport |
| cristae formation |
| ATP biosynthetic process |
| positive regulation of blood pressure |
| positive regulation of heart contraction |
| negative regulation of lipid localization |
| substantia nigra development |
| inner mitochondrial membrane organization |
| purine ribonucleoside triphosphate biosynthetic process |
| purine nucleoside triphosphate biosynthetic process |
| ribonucleoside triphosphate biosynthetic process |
| regulation of organic acid transport |
| purine ribonucleoside triphosphate metabolic process |
| neural nucleus development |
| transmembrane transporter activity |
| nucleoside triphosphate biosynthetic process |
| response to activity |
| ribonucleoside triphosphate metabolic process |
| purine nucleoside triphosphate metabolic process |
| positive regulation of blood circulation |
| midbrain development |
| mitochondrial transmembrane transport |
| nucleoside triphosphate metabolic process |
| regulation of anion transport |
| regulation of heart rate |
| regulation of lipid transport |
| oxidative phosphorylation |
| mitochondrial membrane organization |
| regulation of lipid localization |
| proton transmembrane transport |
| negative regulation of ion transport |
| purine ribonucleotide biosynthetic process |
| purine nucleotide biosynthetic process |
| ribonucleotide biosynthetic process |
| ribose phosphate biosynthetic process |
| purine-containing compound biosynthetic process |
| regulation of blood pressure |
| ATP metabolic process |
| mitochondrial transport |
| negative regulation of secretion |
| ATPase activity |
| regulation of heart contraction |
| nucleotide biosynthetic process |
| nucleoside phosphate biosynthetic process |
| protein-containing complex binding |
| regulation of blood circulation |
| purine ribonucleotide metabolic process |
| ribonucleotide metabolic process |
| purine nucleotide metabolic process |
| ribose phosphate metabolic process |
| purine-containing compound metabolic process |
| blood circulation |
| mitochondrial inner membrane |
| circulatory system process |
| monovalent inorganic cation transport |
| generation of precursor metabolites and energy |
| mitochondrion organization |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| negative regulation of transport |
| drug metabolic process |
| organophosphate biosynthetic process |
| nucleobase-containing small molecule metabolic process |
| inorganic cation transmembrane transport |
| regulation of system process |
| cation transmembrane transport |
| cell surface |
| carbohydrate derivative biosynthetic process |
| inorganic ion transmembrane transport |
| regulation of ion transport |
| brain development |
| head development |
| regulation of secretion |
| cation transport |
| membrane organization |
| organophosphate metabolic process |
| ion transmembrane transport |
| central nervous system development |
| carbohydrate derivative metabolic process |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| mitochondrion |
| transmembrane transport |
| phosphorylation |
| organic cyclic compound biosynthetic process |
| ion transport |
| organonitrogen compound biosynthetic process |
| intracellular transport |
| extracellular space |
| cellular nitrogen compound biosynthetic process |
| positive regulation of multicellular organismal process |
| small molecule metabolic process |
| establishment of localization in cell |
| regulation of transport |
| system process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| ATP5B | 0.628 |
| GFPT1 | 0.625 |
| THG1L | 0.613 |
| GMPPB | 0.606 |
| ATP5O | 0.589 |
| UAP1 | 0.588 |
| ALG1 | 0.583 |
| DPAGT1 | 0.576 |
| RNMT | 0.576 |
| HCCS | 0.573 |
| HSPD1 | 0.573 |
| PMM2 | 0.571 |
| ATP5A1 | 0.571 |
| CYCS | 0.567 |
| TRIAP1 | 0.565 |
| ATP5I | 0.559 |
| ENY2 | 0.556 |
| ATP5D | 0.555 |
| RPTOR | 0.553 |
| UBE2G2 | 0.552 |
| DOHH | 0.552 |
| EXOC4 | 0.544 |
| ATXN10 | 0.535 |
| ALG2 | 0.535 |
| CASP9 | 0.533 |
| ALG13 | 0.532 |
| SLC25A26 | 0.531 |
| ATP5C1 | 0.53 |
| DARS2 | 0.525 |
| ALG5 | 0.522 |
| ADSL | 0.519 |
| BCS1L | 0.515 |
| DIABLO | 0.515 |
| RTCB | 0.512 |
| PLAA | 0.51 |
| LSM10 | 0.509 |
| PPA2 | 0.508 |
| FAF2 | 0.507 |
| MRPS14 | 0.506 |
| ELAC2 | 0.504 |
| DOLK | 0.501 |
| ATP5F1 | 0.499 |
| RPP21 | 0.493 |
| TUFM | 0.492 |
| APAF1 | 0.486 |
| HSD17B10 | 0.485 |
| MRP63 | 0.485 |
| UBA3 | 0.484 |
| VEZT | 0.481 |
| MBTPS2 | 0.478 |
| NAE1 | 0.478 |
| LSM11 | 0.477 |
| COX16 | 0.475 |
| SUPV3L1 | 0.475 |
| FH | 0.475 |
| UHRF1 | 0.474 |
| MTOR | 0.474 |
| TMEM242 | 0.474 |
| CSNK2B | 0.474 |
| OPA1 | 0.473 |
| DHPS | 0.473 |
| SSB | 0.47 |
| GNB1L | 0.469 |
| MED16 | 0.468 |
| BAP1 | 0.467 |
| THOC6 | 0.467 |
| GTF3C6 | 0.466 |
| GTF3C3 | 0.465 |
| CCDC101 | 0.465 |
| SLC25A19 | 0.465 |
| KDSR | 0.465 |
| RPUSD4 | 0.464 |
| ATP5L | 0.461 |
| POLR3H | 0.461 |
| CBFB | 0.459 |
| BAK1 | 0.459 |
| MRPL21 | 0.459 |
| DHRSX | 0.458 |
| NUPL2 | 0.457 |
| AARS | 0.457 |
| SRP14 | 0.456 |
| TMED10 | 0.455 |
| MRPS33 | 0.455 |
| ATP5H | 0.453 |
| TSEN54 | 0.452 |
| HARS | 0.451 |
| ZBTB11 | 0.451 |
| YARS2 | 0.45 |
| NARS | 0.449 |
| YARS | 0.449 |
| MEAF6 | 0.449 |
| DNAJC3 | 0.449 |
| CTDNEP1 | 0.446 |
| TAMM41 | 0.446 |
| MAPK14 | 0.446 |
| CRLS1 | 0.445 |
| MRPS16 | 0.445 |
| CCT7 | 0.444 |
| TRMT5 | 0.443 |
| MRPS6 | 0.443 |
| SARS2 | 0.442 |
| C10orf2 | 0.442 |
| DAP3 | 0.442 |
| TMEM41B | 0.442 |
| TAZ | 0.441 |
| PGM3 | 0.439 |
| ALG6 | 0.438 |
| WDR59 | 0.437 |
| GTF3C2 | 0.437 |
| RPE | 0.436 |
| NXT1 | 0.436 |
| TTI1 | 0.435 |
| MLLT1 | 0.434 |
| TIMM13 | 0.433 |
| SRD5A3 | 0.433 |
| PNPT1 | 0.432 |
| MRPS26 | 0.431 |
| EEF1E1 | 0.431 |
| LAMTOR5 | 0.43 |
| TRNT1 | 0.429 |
| SLC35B1 | 0.428 |
| ATP5E | 0.428 |
| ROMO1 | 0.427 |
| CHCHD4 | 0.427 |
| PPP4C | 0.426 |
| DPF2 | 0.426 |
| TRMT10A | 0.425 |
| WDR24 | 0.424 |
| DR1 | 0.424 |
| COX7B | 0.423 |
| SEC16A | 0.423 |
| PELO | 0.423 |
| TSEN34 | 0.423 |
| PPP2R3C | 0.422 |
| MED4 | 0.422 |
| MRPS34 | 0.422 |
| GABPA | 0.422 |
| PDSS1 | 0.421 |
| GFM1 | 0.421 |
| ZRSR2 | 0.419 |
| PPP6C | 0.419 |
| NDUFAF4 | 0.418 |
| UBE2K | 0.417 |
| MRPL15 | 0.417 |
| WBSCR16 | 0.416 |
| MFN1 | 0.416 |
| SERF2 | 0.413 |
| MED25 | 0.413 |
| SEC62 | 0.412 |
| GTF3C4 | 0.411 |
| UFM1 | 0.411 |
| VARS2 | 0.409 |
| EIF4E | 0.409 |
| DHX29 | 0.409 |
| MRPS9 | 0.408 |
| SCO2 | 0.408 |
| SELRC1 | 0.408 |
| UBE2J1 | 0.406 |
| URM1 | 0.405 |
| HAUS8 | 0.405 |
| TEFM | 0.405 |
| DAD1 | 0.405 |
| GFER | 0.404 |
| VMP1 | 0.404 |
| PPCS | 0.402 |
| MARCH5 | 0.402 |
| SDHA | 0.402 |
| UQCRQ | 0.401 |
| UBQLN1 | 0.401 |
| TBP | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 1/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 1/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 5751
- Expression level (log2 read counts): 5.79
Expression Distribution
ATP5J Expression in NALM6 Cells: 5.79